| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.27B | +6.6% |
| Cost of Revenue | $3.25B | +7.7% |
| Gross Profit | $3.02B | +5.5% |
| R&D Expense | $507.5M | -2.0% |
| SG&A Expense | $452.4M | +8.2% |
| Operating Income | $1.44B | +6.9% |
| Interest Expense | $434.7M | -6.1% |
| Pre-tax Income | $974.8M | +9.1% |
| Income Tax | $176.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $462.1M | -18.5% |
| Accounts Receivable | $978.7M | +8.5% |
| Current Assets | $5.49B | +12.9% |
| Total Assets | $20.71B | +8.8% |
| Current Liabilities | $5.11B | +17.4% |
| Long-term Debt | $7.41B | +6.0% |
| Total Liabilities | $13.77B | +10.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.74B | +25.7% |
| Capital Expenditures | $80.8M | +31.6% |
| Investing Cash Flow | -$1.31B | -52.8% |
| Financing Cash Flow | -$243.5M | -59.9% |
| Free Cash Flow | $1.66B | +25.4% |
| +33.4% |
| Net Income | $796.9M | +4.8% |
| EPS (Basic) | $3.26 | +5.5% |
| EPS (Diluted) | $3.15 | +5.0% |
| Stockholders' Equity |
| $6.89B |
| +5.4% |